QA: MANNKIND CORP in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899460_2020_MANNKIND_CORP.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.07922072713417691, 'aggregate_val': 107635000, 'exp_sum': 99734000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 20078000, 'SellingGeneralAndAdministrativeExpense': 74669000, 'ResearchAndDevelopmentExpense': 6900000, 'remainder_Expenses': -1913000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000899460')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899460, MANNKIND CORP

  xvar xval
0 AssetsCurrent 60,757,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 26,778,000
3 remainder_Assets 6,190,000
4 LiabilitiesCurrent 65,618,000
5 LiabilitiesNoncurrent 10,858,000
6 remainder_Liabilities 207,775,000
7 CostOfGoodsAndServicesSold 20,078,000
8 SellingGeneralAndAdministrativeExpense 74,669,000
9 ResearchAndDevelopmentExpense 6,900,000
10 remainder_Expenses 5,988,000
11 remainder_Revenues 63,038,000
12 remainder_NetIncome -7,306,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 93,725,000
1 Liabilities 284,251,000
2 Expenses 107,635,000
3 Revenues 63,038,000
4 StockholdersEquity -190,526,000
5 NetIncome -51,903,000
6 ComprehensiveNetIncome -51,903,000
7 BaseVar 277,977,500
8 EconomicCapitalRatio -2.01

Edgar->Model Mapping

Feature Distribution

Change over Time